 |
| Reuters |
The verdict of the European Court of Human Rights (ECHR) in the case of Caster Semenya raises "serious questions" about the validity of World Athletics’ requirement that female athletes with high natural testosterone levels take drugs to lower it, the South African athlete said on Wednesday.
The ECHR ruled, by a slender majority of four votes to three, on Tuesday that the double Olympic 800m champion's original appeal against World Athletics regulations had not been properly heard by the Swiss Federal Tribunal, criticising the process followed rather than the verdict reached.
